Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Molecular Cancer | journal | 8.222 Q1 | 196 | 190 | 525 | 23895 | 14728 | 449 | 23.31 | 125.76 | 38.33 | |
2 | Genome Medicine | journal | 4.975 Q1 | 123 | 114 | 435 | 7848 | 4993 | 428 | 9.67 | 68.84 | 43.43 | |
3 | EMBO Molecular Medicine | journal | 3.964 Q1 | 142 | 165 | 440 | 9076 | 3842 | 381 | 8.20 | 55.01 | 45.15 | |
4 | Journal for ImmunoTherapy of Cancer | journal | 3.728 Q1 | 117 | 445 | 1590 | 19408 | 14743 | 1571 | 8.71 | 43.61 | 42.99 | |
5 | Experimental and Molecular Medicine | journal | 3.671 Q1 | 115 | 217 | 535 | 16561 | 6549 | 524 | 9.18 | 76.32 | 39.80 | |
6 | Biomarker Research | journal | 3.024 Q1 | 48 | 101 | 252 | 9121 | 2382 | 228 | 8.45 | 90.31 | 41.22 | |
7 | Clinical and Translational Medicine | journal | 2.424 Q1 | 18 | 0 | 96 | 0 | 546 | 47 | 5.69 | 0.00 | 0.00 | |
8 | Molecular Oncology | journal | 1.940 Q1 | 113 | 203 | 659 | 10551 | 4100 | 641 | 5.42 | 51.98 | 44.33 | |
9 | Molecular Therapy - Methods and Clinical Development | journal | 1.896 Q1 | 60 | 200 | 620 | 9063 | 3131 | 607 | 4.54 | 45.32 | 42.94 | |
10 | Cell Stress | journal | 1.852 Q1 | 27 | 12 | 67 | 632 | 350 | 67 | 3.53 | 52.67 | 40.32 | |
11 | Molecular Therapy - Nucleic Acids | journal | 1.849 Q1 | 95 | 293 | 975 | 15668 | 6807 | 944 | 6.26 | 53.47 | 43.68 | |
12 | Journal of Nanobiotechnology | journal | 1.840 Q1 | 109 | 478 | 1132 | 37071 | 12176 | 1131 | 10.46 | 77.55 | 41.81 | |
13 | Stem Cell Research and Therapy | journal | 1.798 Q1 | 122 | 369 | 1588 | 25576 | 11883 | 1580 | 6.97 | 69.31 | 45.54 | |
14 | Human Genetics and Genomics Advances | journal | 1.713 Q1 | 13 | 69 | 110 | 3480 | 383 | 107 | 3.55 | 50.43 | 51.03 | |
15 | Molecular Therapy - Oncolytics | journal | 1.494 Q1 | 42 | 97 | 488 | 5554 | 2595 | 478 | 5.35 | 57.26 | 43.28 | |
16 | Cellular oncology (Dordrecht) | journal | 1.489 Q1 | 58 | 147 | 252 | 9711 | 1445 | 250 | 5.11 | 66.06 | 44.03 | |
17 | Molecular Biomedicine | journal | 1.455 Q1 | 16 | 49 | 107 | 6324 | 565 | 101 | 5.32 | 129.06 | 46.29 | |
18 | Molecular Medicine | journal | 1.446 Q1 | 133 | 164 | 433 | 10606 | 2403 | 430 | 5.50 | 64.67 | 43.02 | |
19 | Expert Review of Vaccines | journal | 1.412 Q1 | 105 | 110 | 409 | 7915 | 2013 | 364 | 5.10 | 71.95 | 43.87 | |
20 | Journal of Cellular and Molecular Medicine | journal | 1.207 Q2 | 157 | 363 | 2685 | 17174 | 13010 | 2661 | 4.39 | 47.31 | 43.38 | |
21 | Human Genomics | journal | 1.199 Q2 | 68 | 113 | 186 | 6418 | 681 | 176 | 3.51 | 56.80 | 49.55 | |
22 | Clinical Proteomics | journal | 1.015 Q2 | 42 | 55 | 117 | 3191 | 442 | 113 | 2.81 | 58.02 | 39.31 | |
23 | Function | journal | 0.987 Q2 | 16 | 74 | 173 | 3180 | 401 | 136 | 2.18 | 42.97 | 39.01 | |
24 | Biomarker Insights | journal | 0.974 Q2 | 40 | 9 | 67 | 468 | 246 | 59 | 3.34 | 52.00 | 50.00 | |
25 | Cancer Biology and Therapy | journal | 0.914 Q2 | 130 | 83 | 267 | 3691 | 956 | 263 | 4.32 | 44.47 | 45.15 | |
26 | Molecular Pain | journal | 0.904 Q2 | 96 | 60 | 203 | 3203 | 663 | 202 | 2.74 | 53.38 | 41.30 | |
27 | Journal of Pharmacological Sciences | journal | 0.876 Q2 | 101 | 80 | 324 | 3004 | 1106 | 324 | 3.23 | 37.55 | 31.80 | |
28 | AIDS Research and Therapy | journal | 0.872 Q2 | 49 | 89 | 234 | 3234 | 555 | 234 | 2.18 | 36.34 | 48.99 | |
29 | SLAS Discovery | journal | 0.869 Q2 | 33 | 59 | 289 | 2627 | 828 | 269 | 2.86 | 44.53 | 35.53 | |
30 | EXCLI Journal | journal | 0.853 Q2 | 55 | 94 | 353 | 5995 | 1144 | 256 | 3.13 | 63.78 | 41.51 | |
31 | Frontiers in Genetics | journal | 0.853 Q2 | 120 | 1928 | 8231 | 104170 | 24943 | 7934 | 2.73 | 54.03 | 44.01 | |
32 | Pharmaceuticals | journal | 0.845 Q2 | 87 | 1734 | 3398 | 132346 | 15899 | 3385 | 4.55 | 76.32 | 47.92 | |
33 | Drugs in Context | journal | 0.811 Q2 | 36 | 58 | 193 | 3370 | 574 | 193 | 2.46 | 58.10 | 41.20 | |
34 | Journal of Experimental Pharmacology | journal | 0.778 Q2 | 23 | 41 | 153 | 1868 | 578 | 152 | 3.76 | 45.56 | 30.72 | |
35 | FASEB BioAdvances | journal | 0.764 Q2 | 18 | 40 | 210 | 1940 | 560 | 202 | 2.52 | 48.50 | 41.53 | |
36 | Pharmaceutical Biology | journal | 0.754 Q2 | 88 | 134 | 526 | 6483 | 2160 | 524 | 4.06 | 48.38 | 45.80 | |
37 | Molecules | journal | 0.744 Q3 | 227 | 8149 | 22863 | 524910 | 110930 | 22705 | 4.46 | 64.41 | 44.69 | |
38 | Analytical Cellular Pathology | journal | 0.711 Q3 | 35 | 41 | 179 | 1741 | 523 | 177 | 2.61 | 42.46 | 39.25 | |
39 | Vaccine: X | journal | 0.682 Q3 | 18 | 163 | 168 | 6099 | 452 | 168 | 2.80 | 37.42 | 49.48 | |
40 | European Journal of Medicinal Chemistry Reports | journal | 0.588 Q3 | 11 | 22 | 86 | 1972 | 367 | 86 | 4.27 | 89.64 | 28.81 | |
41 | Biomimetics | journal | 0.562 Q3 | 32 | 620 | 386 | 37616 | 1639 | 378 | 3.76 | 60.67 | 33.98 | |
42 | Molecular Imaging | journal | 0.514 Q3 | 66 | 9 | 60 | 606 | 128 | 60 | 1.97 | 67.33 | 42.42 | |
43 | Pharmacogenomics and Personalized Medicine | journal | 0.508 Q3 | 37 | 95 | 303 | 4240 | 582 | 301 | 1.94 | 44.63 | 42.08 | |
44 | European Journal of Hybrid Imaging | journal | 0.479 Q3 | 14 | 28 | 87 | 773 | 183 | 87 | 1.73 | 27.61 | 37.23 | |
45 | Molecular and Cellular Oncology | journal | 0.471 Q3 | 37 | 4 | 244 | 155 | 237 | 156 | 0.88 | 38.75 | 41.67 | |
46 | Molecular Cytogenetics | journal | 0.403 Q4 | 38 | 36 | 160 | 1356 | 225 | 159 | 1.43 | 37.67 | 62.60 | |
47 | Biointerface Research in Applied Chemistry | journal | 0.384 Q4 | 30 | 597 | 1449 | 34599 | 3937 | 1446 | 2.91 | 57.95 | 40.41 | |
48 | Turkish Journal of Pharmaceutical Sciences | journal | 0.364 Q4 | 22 | 50 | 289 | 1621 | 625 | 279 | 2.09 | 32.42 | 55.23 | |
49 | Exploration of Medicine | journal | 0.320 Q4 | 9 | 55 | 118 | 3915 | 184 | 113 | 1.07 | 71.18 | 48.46 | |
50 | Nanomedicine Research Journal | journal | 0.304 Q4 | 20 | 39 | 120 | 1819 | 243 | 120 | 1.85 | 46.64 | 46.90 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®